This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD8A, based on 67 published articles (read how Labome selects the articles), using CD8A antibody in all methods. It is aimed to help Labome visitors find the most suited CD8A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD8A synonym: T-cell surface glycoprotein CD8 alpha chain

BioLegend
mouse monoclonal (RPA-T8)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CD8A antibody (Biolegend, 301002) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s1b). J Immunol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (Biolegend, 344702) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s4b
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s4b). Sci Immunol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on mouse samples (fig 2b). Mucosal Immunol (2018) ncbi
mouse monoclonal (RPA-T8)
  • immunohistochemistry; human; 5 mg/ml; loading ...; fig s1b
BioLegend CD8A antibody (Biolegend, RPTA-T8) was used in immunohistochemistry on human samples at 5 mg/ml (fig s1b). Curr Biol (2018) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 4f
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 4f). J Clin Invest (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (BioLegend, 344708) was used in flow cytometry on human samples (fig 3a). Biol Reprod (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 1c). J Clin Invest (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig s2e
BioLegend CD8A antibody (BioLegend, 344731) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 2c). J Virol (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 3a). Antimicrob Agents Chemother (2018) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (SK1)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD8A antibody (BioLegend, SK1) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s5a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend CD8A antibody (biolegend, RPA-T8) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; African green monkey; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BioLegend CD8A antibody (biolegend, RPA-T8) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD8A antibody (BioLegend, 301049) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD8A antibody (BioLegend, 301012) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; Rhesus monkey; loading ...; fig 1d
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on Rhesus monkey samples (fig 1d). PLoS Pathog (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; fig s3b
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on mouse samples (fig s3b). Nat Commun (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:100; loading ...; fig 1
In order to report the effect of antiretroviral treatment initiation and different antiretroviral treatment regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:50; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples at 1:50 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (SK1)
  • flow cytometry; mouse; fig 3i
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on mouse samples (fig 3i). J Exp Med (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig s8). Science (2016) ncbi
mouse monoclonal (RPA-T8)
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BioLegend CD8A antibody (Biolegend, 301048) was used . J Virol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 6e
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 6e). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:50; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples at 1:50 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s4a
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; Rhesus monkey; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD8A antibody (BioLegend, 301037) was used in flow cytometry on Rhesus monkey samples . Nat Med (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD8A antibody (Biolegend, RPAT8) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; Rhesus monkey; loading ...; fig 8b
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on Rhesus monkey samples (fig 8b). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 2b
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples (fig 2b). Am J Transplant (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 1:50; fig 6
BioLegend CD8A antibody (Biolegend, RPA T8) was used in flow cytometry on human samples at 1:50 (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; 10 ug/ml
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples at 10 ug/ml. Nat Commun (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BioLegend CD8A antibody (Biolegend, 301010) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; loading ...; fig 1b
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD8A antibody (biolegend, RPA-T8) was used in flow cytometry on human samples (fig 1b). J Immunol (2016) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; Rhesus monkey; fig 3
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on Rhesus monkey samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (SK1)
  • flow cytometry; Rhesus monkey; loading ...; fig s2
In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on Rhesus monkey samples (fig s2). PLoS ONE (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; 1:20
In order to describe the CD161(hi)TRAV1-2(+) TCR repertoire, BioLegend CD8A antibody (Biolegend, 344707) was used in flow cytometry on human samples at 1:20. Hum Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human; fig s1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; Rhesus monkey; fig 1
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on Rhesus monkey samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, BioLegend CD8A antibody (Biolegend, RPA-T8) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; tbl s1
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, 301026) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; fig 2
BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 2). Cancer Immunol Res (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
BioLegend CD8A antibody (BioLegend, RPA-T8) was used . J Leukoc Biol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human
BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples . Cell Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; Rhesus monkey
BioLegend CD8A antibody (BioLegend, RPA-T8) was used in flow cytometry on Rhesus monkey samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T8)
  • flow cytometry; human
BioLegend CD8A antibody (Biolegend, clone RPA-T8) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend CD8A antibody (Biolegend, SK1) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (SK1)
  • immunocytochemistry; human
BioLegend CD8A antibody (BioLegend, SK1) was used in immunocytochemistry on human samples . J Cell Physiol (2014) ncbi
mouse monoclonal (SK1)
  • flow cytometry; human; loading ...; fig 2
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CD8A antibody (BioLegend, SK1) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2014) ncbi
Bio-Rad
rat monoclonal (YTC182.20)
  • immunohistochemistry; African green monkey; loading ...
In order to perform an enhanced embryo-fetal development investigation using pateclizumab in cynomolgus monkeys, Bio-Rad CD8A antibody (AbD Serotec, MCA351G) was used in immunohistochemistry on African green monkey samples . Reprod Toxicol (2016) ncbi
mouse monoclonal (RPA-T8)
  • immunohistochemistry; African green monkey; 1:100
In order to study the neurotoxicity of AAV9-mediated expression of a non-self protein in nonhuman primates, Bio-Rad CD8A antibody (AbD-Serotec, MCA4609T) was used in immunohistochemistry on African green monkey samples at 1:100. Mol Ther (2014) ncbi
Articles Reviewed
  1. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  2. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  3. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  4. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  5. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  6. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  7. Trapecar M, Khan S, Cohn B, Wu F, Sanjabi S. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol. 2018;11:1158-1167 pubmed publisher
  8. Carisey A, Mace E, Saeed M, Davis D, Orange J. Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells. Curr Biol. 2018;28:489-502.e9 pubmed publisher
  9. Huang S, Ren Y, Thomas A, Chan D, Mueller S, Ward A, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J Clin Invest. 2018;128:876-889 pubmed publisher
  10. Warthan M, Washington S, Franzese S, Ramus R, Kim K, York T, et al. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod. 2018;98:309-322 pubmed publisher
  11. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  12. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  13. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  14. Meng W, Tang A, Ye X, Gui X, Li L, Fan X, et al. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody. Antimicrob Agents Chemother. 2018;62: pubmed publisher
  15. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  16. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  17. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  18. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  19. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  20. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  21. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  22. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  23. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  24. Wahl S, Drong A, Lehne B, Loh M, Scott W, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81-86 pubmed publisher
  25. Tripathi D, Venkatasubramanian S, Cheekatla S, Paidipally P, Welch E, Tvinnereim A, et al. A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice. Nat Commun. 2016;7:13896 pubmed publisher
  26. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed publisher
  27. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  28. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  29. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  30. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  31. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  32. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  33. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  34. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  35. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  36. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  37. Daud A, Loo K, Pauli M, Sanchez Rodriguez R, Sandoval P, Taravati K, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126:3447-52 pubmed publisher
  38. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  39. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  40. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  41. Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer G, Habermann G, et al. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates. Reprod Toxicol. 2016;63:82-95 pubmed publisher
  42. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  43. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  44. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  45. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  46. Khazen R, Müller S, Gaudenzio N, Espinosa E, Puissegur M, Valitutti S. Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse. Nat Commun. 2016;7:10823 pubmed publisher
  47. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  48. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  49. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  50. Javed A, Leuchte N, Neumann B, Sopper S, Sauermann U. Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS ONE. 2015;10:e0142086 pubmed publisher
  51. Held K, Beltrán E, Moser M, Hohlfeld R, Dornmair K. T-cell receptor repertoire of human peripheral CD161hiTRAV1-2+ MAIT cells revealed by next generation sequencing and single cell analysis. Hum Immunol. 2015;76:607-14 pubmed publisher
  52. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  53. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  54. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  55. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  56. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  57. Bradley S, Chen Z, Melendez B, Talukder A, Khalili J, Rodríguez Cruz T, et al. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunol Res. 2015;3:602-9 pubmed publisher
  58. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  59. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  60. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher
  61. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  62. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  63. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  64. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  65. Samaranch L, Sebastián W, Kells A, Salegio E, Heller G, Bringas J, et al. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Mol Ther. 2014;22:329-337 pubmed publisher
  66. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  67. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher